Workflow
居里(CRIS)
icon
搜索文档
Curis(CRIS) - 2022 Q2 - Earnings Call Presentation
2022-08-04 23:12
Corporate Presentation NASDAQ: CRIS Cautionary Note Regarding Forward Looking Statements This presentation contains certain forward-looking statements about Curis, Inc. ("we," "us," or the "Company") within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Words such as "expect(s)," "believe(s)," "will," "may," "anticipate(s)," "focus(es)," "plans," "mission," "strategy," "potential," "estimate(s)", "intend," "project," "seek," "should," "would" and similar expressions are int ...
Curis(CRIS) - 2022 Q2 - Quarterly Report
2022-08-04 00:00
Table of Contents Title of each class Trading Symbol Name of each exchange on which registered UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-30347 CURIS, INC. (Exact Name o ...
Curis(CRIS) - 2022 Q1 - Earnings Call Transcript
2022-05-06 06:55
Curis, Inc. (NASDAQ:CRIS) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Craig West - Vice President of Investor Relations and Corporate Communications Jim Dentzer - President and Chief Executive Officer Bill Steinkrauss - Chief Financial Officer and Chief Administrative Officer Bob Martell - Head of R&D Conference Call Participants Soumit Roy - Jones Research Yale Jen - Laidlaw and Company Disclaimer*: This transcript is designed to be used alongside the freely available audio ...
Curis(CRIS) - 2022 Q1 - Quarterly Report
2022-05-05 00:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-30347 CURIS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 04-3505116 (State or Othe ...
Curis(CRIS) - 2021 Q4 - Earnings Call Transcript
2022-02-25 10:58
Curis Inc. (NASDAQ:CRIS) Q4 2021 Earnings Conference Call February 24, 2022 4:30 PM ET Company Participants James Dentzer – President & Chief Executive Officer Bill Steinkrauss – Chief Financial Officer & Chief Administrative Officer Bob Martell – Head of R&D Conference Call Participants Alethia Young – Cantor Fitzgerald Edward White – HC Wainwright Yale Jen – Laidlaw and Company Danya Ben-Hail – Jones Trading Dane Leone – Raymond James Operator Good afternoon. And welcome to Curis' Fourth Quarter and year- ...
Curis(CRIS) - 2021 Q4 - Annual Report
2022-02-24 00:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________ FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 000-30347 CURIS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 04-3505116 (State or other jurisdiction of incorpora ...
Curis (CRIS) Investor Presentation - Slideshow
2022-01-29 07:01
Corporate Presentation NASDAQ: CRIS Cautionary Note Regarding Forward Looking Statements This presentation contains certain forward-looking statements about Curis, Inc. ("we," "us," or the "Company") within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Words such as "expect(s)," "believe(s)," "will," "may," "anticipate(s)," "focus(es)," "plans," "mission," "strategy," "potential," "estimate(s)", "intend," "project," "seek," "should," "would" and similar expressions are int ...
Curis(CRIS) - 2021 Q3 - Earnings Call Transcript
2021-11-10 11:38
Curis, Inc. (NASDAQ:CRIS) Q3 2021 Results Earnings Conference Call November 9, 2021 4:30 PM ET Company Participants Elif McDonald - VP of Investor Relations and Corporate Communications Bill Steinkrauss - Chief Financial Officer James Dentzer - President and Chief Executive Officer Bob Martell - Head of R&D Conference Call Participants Alethia Young - Cantor Dane Leone - Raymond James Justin Walsh - B. Riley Securities Soumit Roy - Jones Trading Operator Good afternoon and welcome to the Curis Third Quarter ...
Curis(CRIS) - 2021 Q3 - Quarterly Report
2021-11-09 00:00
Table of Contents Title of each class Trading Symbol Name of each exchange on which registered UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-30347 CURIS, INC. (Exact N ...
Curis(CRIS) - 2021 Q2 - Earnings Call Transcript
2021-08-04 10:04
Curis, Inc. (NASDAQ:CRIS) Q2 2021 Earnings Conference Call August 3, 2021 4:30 PM ET Company Participants Bill Steinkrauss – Chief Financial Officer Jim Dentzer – President and Chief Executive Officer Bob Martell – Head of R&D Conference Call Participants Justin Walsh – B. Riley Securities Yale Jen – Laidlaw & Co. Operator Good afternoon and welcome to the Curis Second Quarter 2021 Earnings Call. All participants will be in a listen-only mode. [Operator instructions] After the company's prepared remarks, ca ...